Advancing CNS Drug Development: Integrated Strategies Across Discovery, DMPK, and Non-Clinical Safety

Advancing CNS Drug Development is an American Chemical Society event session that brings together experts in CNS discovery, translational pharmacology, DMPK, and non-clinical safety. Speakers discuss target validation, brain exposure and distribution, and translational insights from early discovery through IND-enabling studies. The session features industry researchers with experience in neuropharmacology, DMPK, and safety pharmacology.

Register via the ACS event registration link